4:56 PM
 | 
Oct 07, 2013
 |  BC Extra  |  Top Story

Mitokyne raises $45M, partners with Astellas

Mitokyne Inc. (Boston, Mass.) raised $45 million in a series A round and exclusively partnered with Astellas Pharma Inc. (Tokyo:4503) to discover and develop compounds that target mitochondrial function. Astellas, which invested in the round,...

Read the full 158 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >